RGD Reference Report - Angiotensin II regulates V2 receptor and pAQP2 during ureteral obstruction. - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

Angiotensin II regulates V2 receptor and pAQP2 during ureteral obstruction.

Authors: Jensen, AM  Bae, EH  Fenton, RA  Norregaard, R  Nielsen, S  Kim, SW  Frokiaer, J 
Citation: Jensen AM, etal., Am J Physiol Renal Physiol. 2009 Jan;296(1):F127-34. Epub 2008 Oct 29.
RGD ID: 2312654
Pubmed: PMID:18971210   (View Abstract at PubMed)
DOI: DOI:10.1152/ajprenal.90479.2008   (Journal Full-text)

Release of bilateral ureteral obstruction (BUO) is associated with nephrogenic diabetes insipidus (NDI) and a reduced abundance of the vasopressin-regulated aquaporins. To evaluate the role of the vasopressin type 2 receptor (V2R), we determined V2R abundance in kidneys from rats subjected to 24-h BUO or 24-h unilateral ureteral obstruction (UUO) followed by 48-h release. Because angiotensin II type 1 (AT1) receptor blockade attenuates postobstructive polyuria and aquaporin-2 (AQP2) downregulation, we examined the effect of AT1 receptor blockade on AQP2 phosphorylated at serine 256 (pS256-AQP2) and V2 receptor complex abundance in kidney inner medulla (IM). Furthermore, cAMP generation in sodium fluoride- and forskolin-stimulated inner medullary membrane fractions was studied after release of BUO. V2R was significantly reduced to 12% of sham levels in IM and to 52% of sham levels in cortex and outer stripe of outer medulla (OSOM) from BUO rats. In UUO rats, V2R abundance in the obstructed kidney IM decreased to 35% of sham levels, whereas it was comparable to sham levels in the nonobstructed kidney IM. No significant change was observed in cortex and OSOM. AT1 receptor blockade attenuated V2R, pS256-AQP2, and G(s)alpha protein downregulation in IM and partially reversed the obstruction-induced inhibition of sodium fluoride- and forskolin-stimulated cAMP generation in inner medullary membrane fractions from BUO rats. In conclusion, V2R downregulation plays a pivotal role in development of NDI after release of BUO. In addition, we have shown that angiotensin II regulates the V2 receptor complex and pS256-AQP2 in postobstructive kidney IM, probably by stimulating cAMP generation.



RGD Manual Disease Annotations    Click to see Annotation Detail View

  

Gene Ontology Annotations    Click to see Annotation Detail View

Biological Process

  
Object SymbolSpeciesTermQualifierEvidenceWithNotesSourceOriginal Reference(s)
Adcy6RatcAMP biosynthetic process  IMP  RGD 

Cellular Component

  
Object SymbolSpeciesTermQualifierEvidenceWithNotesSourceOriginal Reference(s)
Aqp2Ratapical plasma membrane  IDA  RGD 

Molecular Pathway Annotations    Click to see Annotation Detail View

RGD Manual Annotations


  
Object SymbolSpeciesTermQualifierEvidenceWithNotesSourceOriginal Reference(s)
ADCY6Humanvasopressin signaling pathway   ISOAdcy6 (Rattus norvegicus) RGD 
AQP2Humanvasopressin signaling pathway   ISOAqp2 (Rattus norvegicus) RGD 
AVPR2Humanvasopressin signaling pathway   ISOAvpr2 (Rattus norvegicus) RGD 
Adcy6Mousevasopressin signaling pathway   ISOAdcy6 (Rattus norvegicus) RGD 
Adcy6Ratvasopressin signaling pathway   IMP  RGD 
Aqp2Mousevasopressin signaling pathway   ISOAqp2 (Rattus norvegicus) RGD 
Aqp2Ratvasopressin signaling pathway   IMP  RGD 
Avpr2Mousevasopressin signaling pathway   ISOAvpr2 (Rattus norvegicus) RGD 
Avpr2Ratvasopressin signaling pathway   IMP  RGD 
GNASHumanvasopressin signaling pathway   ISOGnas (Rattus norvegicus) RGD 
GnasRatvasopressin signaling pathway   IMP  RGD 
GnasMousevasopressin signaling pathway   ISOGnas (Rattus norvegicus) RGD 
ADCY6Humanvasopressin signaling pathway via receptor type 2   ISOAdcy6 (Rattus norvegicus) RGD 
AQP2Humanvasopressin signaling pathway via receptor type 2   ISOAqp2 (Rattus norvegicus) RGD 
AVPR2Humanvasopressin signaling pathway via receptor type 2   ISOAvpr2 (Rattus norvegicus) RGD 
Adcy6Mousevasopressin signaling pathway via receptor type 2   ISOAdcy6 (Rattus norvegicus) RGD 
Adcy6Ratvasopressin signaling pathway via receptor type 2   IMP  RGD 
Aqp2Mousevasopressin signaling pathway via receptor type 2   ISOAqp2 (Rattus norvegicus) RGD 
Aqp2Ratvasopressin signaling pathway via receptor type 2   IMP  RGD 
Avpr2Mousevasopressin signaling pathway via receptor type 2   ISOAvpr2 (Rattus norvegicus) RGD 
Avpr2Ratvasopressin signaling pathway via receptor type 2   IMP  RGD 
GNASHumanvasopressin signaling pathway via receptor type 2   ISOGnas (Rattus norvegicus) RGD 
GnasRatvasopressin signaling pathway via receptor type 2   IMP  RGD 
GnasMousevasopressin signaling pathway via receptor type 2   ISOGnas (Rattus norvegicus) RGD 
Objects Annotated

Genes (Rattus norvegicus)
Adcy6  (adenylate cyclase 6)
Aqp2  (aquaporin 2)
Avpr2  (arginine vasopressin receptor 2)
Gnas  (GNAS complex locus)

Genes (Mus musculus)
Adcy6  (adenylate cyclase 6)
Aqp2  (aquaporin 2)
Avpr2  (arginine vasopressin receptor 2)
Gnas  (GNAS complex locus)

Genes (Homo sapiens)
ADCY6  (adenylate cyclase 6)
AQP2  (aquaporin 2)
AVPR2  (arginine vasopressin receptor 2)
GNAS  (GNAS complex locus)


Additional Information